Abstract
ABSTRACT This paper draws a comparison between Chinese and US technology policies aimed at generating clustering in biotechnology. It compares characteristics of biotechnology companies and patents that have been created on the east coast of China since the mid-1990s with early US biotechnology clusters. It highlights Chinese policies aimed at returning scientists and directive locational policies. Policy deficiencies include: difficulty in shifting away from government-led responsiveness to funding programmes; failure to set in place governance structures that promote interaction between the domestic science base and domestic firms; and shortcomings in policies towards returnees and the financing of small and medium-sized enterprises (SMEs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
